Statistics for Phase I/II trial of liver–derived mesenchymal stem cells in pediatric liver–based metabolic disorders : a prospective, open label, multicenter, partially randomized, safety study of one cycle of heterologous human adult liver–derived progenitor cells (HepaStem) in urea cycle disorders and Crigler-Najjar syndrome patients
Total visits
| views | |
|---|---|
| Phase I/II trial of liver–derived mesenchymal stem cells in pediatric liver–based metabolic disorders : a prospective, open label, multicenter, partially randomized, safety study of one cycle of heterologous human adult liver–derived progenitor cells (HepaStem) in urea cycle disorders and Crigler-Najjar syndrome patients | 40 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 5 |
| September 2025 | 5 |
| October 2025 | 0 |
| November 2025 | 1 |
| December 2025 | 0 |
File Visits
| views | |
|---|---|
| HepaStem_pediatric.pdf | 2 |
Top country views
| views | |
|---|---|
| United States | 14 |
| China | 7 |
| Portugal | 6 |
| Germany | 4 |
| Vietnam | 3 |
| Djibouti | 1 |
| Ireland | 1 |
| Israel | 1 |
Top city views
| views | |
|---|---|
| Lisbon | 1 |